Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group
Bo Shen,Gursimran Kochhar,Udayakumar Navaneethan,Xiuli Liu,Francis A. Farraye,Yago Gonzalez-Lama,David Bruining,Darrell S. Pardi,Martin Lukas,Martin Bortlik,Kaicun Wu,Ajit Sood,David A. Schwartz,William J. Sandborn,Roger Charles,Yan Chen,Maria Begoña González Suárez,Marietta Iaccuci,Tako Kabayashi,Paulo Kotze,Nan Lan,Yue Li,Ren Mao
DOI: https://doi.org/10.1016/j.gie.2018.09.045
IF: 10.396
2019-02-01
Gastrointestinal Endoscopy
Abstract:Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.
gastroenterology & hepatology